[The six most frequent peripheral vestibular syndromes].
Michael Leo StruppAndreas ZwergalNicolina GoldschaggPublished in: Laryngo- rhino- otologie (2023)
Three forms of peripheral vestibular disorders, each with its typical symptoms and clinical signs, can be differentiated functionally, anatomically and pathophysiologically: 1. inadequate unilateral paroxysmal stimulation or rarely inhibition of the peripheral vestibular system, e. g., BPPV, Menière's disease, vestibular paroxysmia or syndrome of the third mobile windows; 2. acute unilateral vestibulopathy leading to an acute vestibular tone imbalance manifesting as an acute peripheral vestibular syndrome; and 3. loss or impairment of function of the vestibular nerve and/or labyrinth: bilateral vestibulopathy. For all of these diseases, current diagnostic criteria by the Bárány-Society are available with a high clinical and scientific impact, also for clinical trials. The treatment depends on the underlying disease. It basically consists of 5 principles: 1. Explaining the symptoms and signs, pathophysiology, aetiology and treatment options to the patient; this is important for compliance, adherence and persistence. 2. Physical therapy: A) For BPPV specific liberatory maneuvers, depending on canal involved. Posterior canal: The new SémontPLUS maneuver is superior to the regular Sémont and Epley maneuvers; horizontal canal: the modified roll-maneuver; anterior canal the modified Yacovino-maneuver; 3. Symptomatic or causative drug therapy. There is still a deficit of placebo-controlled clinical trials so that the level of evidence for pharmacotherapy is most often low. 4. Surgery, mainly for the syndrome of the third mobile windows. 5. Psychotherapeutic measures for secondary functional dizziness.
Keyphrases
- clinical trial
- liver failure
- hearing loss
- case report
- respiratory failure
- drug induced
- chemotherapy induced
- aortic dissection
- minimally invasive
- emergency department
- type diabetes
- phase ii
- double blind
- study protocol
- squamous cell carcinoma
- placebo controlled
- randomized controlled trial
- intensive care unit
- coronary artery disease
- metabolic syndrome
- coronary artery bypass
- sleep quality
- radiation therapy
- phase iii
- mesenchymal stem cells
- percutaneous coronary intervention
- extracorporeal membrane oxygenation
- replacement therapy
- cell therapy